- Investing Ideas
- Japanese Pharmaceuticals & Biotech Large Cap High Growth Potential
Japanese Pharmaceuticals & Biotech Large Cap High Growth Potential
Results
3
0 new
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
3 companies
Chugai Pharmaceutical
Market Cap: JP¥12.2t
Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.
4519
JP¥7,339.00
7D
3.0%
1Y
3.1%
Takeda Pharmaceutical
Market Cap: JP¥8.9t
Engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products.
4502
JP¥5,551.00
7D
5.0%
1Y
27.8%
Daiichi Sankyo Company
Market Cap: JP¥5.0t
Manufactures and sells pharmaceutical products in Japan and internationally.
4568
JP¥2,761.50
7D
3.2%
1Y
-24.2%